![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![European Crohn´s and Colitis Organisation - ECCO - OP17 Impact of phenotypic and genetic factors on Crohn's Disease evolution in a cohort of 13,926 patients European Crohn´s and Colitis Organisation - ECCO - OP17 Impact of phenotypic and genetic factors on Crohn's Disease evolution in a cohort of 13,926 patients](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000816250/Images/figure1202103091936174533.png)
European Crohn´s and Colitis Organisation - ECCO - OP17 Impact of phenotypic and genetic factors on Crohn's Disease evolution in a cohort of 13,926 patients
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2d8ce941-c21d-47d2-bfdc-8ad0f0503aac/gr1.jpg)